SAM
PFE icon

S.A. Mason’s Pfizer PFE Stock Holding History

S.A. Mason’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Sell
9,104
-274
-3% -$7.17K 0.07% 207
2026
Q1 		$263K Buy
9,378
+534
+6% +$14.2K 0.1% 179
2025
Q4 		$220K Sell
8,844
-181
-2% -$4.56K 0.09% 186
2025
Q3 		$230K Buy
9,025
+26
+0.3% +$642 0.1% 177
2025
Q2 		$218K Buy
8,999
+955
+12% +$22.3K 0.11% 169
2025
Q1 		$204K Sell
8,044
-287
-3% -$7.51K 0.11% 173
2024
Q4 		$221K Buy
8,331
+31
+0.4% +$841 0.12% 162
2024
Q3 		$240K Sell
8,300
-117
-1% -$3.41K 0.13% 153
2024
Q2 		$236K Buy
8,417
+1,001
+13% +$27.6K 0.13% 146
2024
Q1 		$206K Buy
7,416
+30
+0.4% +$832 0.12% 158
2023
Q4 		$213K Sell
7,386
-1,453
-16% -$43.9K 0.14% 145
2023
Q3 		$293K Buy
8,839
+89
+1% +$3.15K 0.21% 117
2023
Q2 		$357K Hold
8,750
– – 0.26% 105
2023
Q1 		$357K Sell
8,750
-275
-3% -$11.9K 0.26% 105
2022
Q4 		$462K Buy
9,025
+14
+0.2% +$671 0.35% 82
2022
Q3 		$394K Buy
9,011
+14
+0.2% +$680 0.31% 90
2022
Q2 		$472K Sell
8,997
-173
-2% -$8.82K 0.34% 82
2022
Q1 		$475K Sell
9,170
-136
-1% -$7.06K 0.3% 92
2021
Q4 		$550K Buy
9,306
+13
+0.1% +$644 0.33% 84
2021
Q3 		$400K Buy
9,293
+1,230
+15% +$54.5K 0.26% 104
2021
Q2 		$316K Buy
8,063
+5
+0.1% +$194 0.22% 124
2021
Q1 		$292K Buy
8,058
+4
+0% +$142 0.22% 120
2020
Q4 		$296K Sell
8,054
-146
-2% -$5.36K 0.25% 108
2020
Q3 		$286K Sell
8,200
-3
-0% -$105 0.27% 98
2020
Q2 		$255K Sell
8,203
-362
-4% -$12.3K 0.27% 101
2020
Q1 		$265K Sell
8,565
-276
-3% -$9.4K 0.32% 90
2019
Q4 		$329K Buy
+8,841
New +$315K 0.31% 95

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

S.A. Mason's PFE Position: Q2 2026 in Review

S.A. Mason reduced its Pfizer (PFE) stake by 2.9% in Q2 2026, selling an estimated $7.17K and leaving 9,104 shares worth $219K. The position accounts for 0.07% of the portfolio, ranked #207.

S.A. Mason first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $550K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • S.A. Mason held 9,104 shares of Pfizer worth $219K as of Q2 2026.
  • S.A. Mason sold 274 Pfizer shares in Q2 2026, an estimated $7.17K.
  • Pfizer made up 0.07% of S.A. Mason's portfolio in Q2 2026, its #207 holding.
  • S.A. Mason first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • S.A. Mason's Pfizer position peaked at $550K in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on S.A. Mason's 13F filing for Q2 2026, filed 31 Jul 2026.